All of the relevant genetic data needed to replicate the meta-analysis, calculation of genotype frequencies, and calculation population attributable risks are available in [Table 1](#pone.0121855.t001){ref-type="table"}. All of the necessary demographic data needed to census tract average population attributable risks and percent population at risk are publicly available from the Census Bureau ([www.factfinder.census.gov](http://www.factfinder.census.gov)) and Centers for Disease Control and Prevention (<http://www.cdc.gov/diabetes/home/index.html>) respectively.

Introduction {#sec006}
============

Communities and public health agencies, such as the US Environmental Protection Agency (EPA), would benefit from being able to quickly screen local communities, and potentially the entire country, for possible geographic "hotspots" for increased risk of developing chronic diseases due to varied socioeconomic, demographic, genetic, and environmental factors. Leveraging data science approaches (i.e., extracting knowledge from multiple, disparate sources of data) should allow for the identification of these geographic areas whose populations are at increased risk due to multiple risk factors.

Emerging evidence suggests that race, socioeconomic factors, and where one lives may adversely impact one's risk of developing type 2 diabetes mellitus (T2DM) \[[@pone.0121855.ref001],[@pone.0121855.ref002]\]. Recent epidemiologic evidence regarding the association of T2DM and environmental contaminants additionally suggests a relationship between some heavy metals (arsenic) and persistent organic pollutants (PCBs, *p*,*p'*-DDE) \[[@pone.0121855.ref003]\]. However, the current evidence fails to support associations with other contaminants such as mercury and cadmium \[[@pone.0121855.ref003]\]. Identified gaps in current epidemiologic database include how co-exposures, comorbidities, and genetic variants modify the association between T2DM and individual environmental pollutants. As genomic determinants of T2DM have been shown to demonstrate heterogeneity across populations \[[@pone.0121855.ref004]\], it is possible that these differential genetic susceptibilities may interact with environmental factors to tip the scale in favor of developing T2DM. Therefore, information regarding the prevalence of genetic polymorphisms conferring increased risks of developing T2DM within various human populations would allow for the identification of potentially susceptible populations. Finally, the locations where these susceptible populations live can be identified through the use of census data, and geographic information systems (GIS) can be used to generate maps to display those hotspots of genetic risk. As a pilot study, this analysis focused on the state of California and the characterization of the risk of developing T2DM in three separate ethnic groups due to a single nucleotide polymorphism (SNP).

Materials and Methods {#sec007}
=====================

Genetic Data Mining {#sec008}
-------------------

We performed literature and database searches to identify several genotypes that have been shown to be associated with T2DM \[[@pone.0121855.ref005]\]. As a pilot study, we decided to focus on the C/T rs13266634 polymorphism in the solute carrier family 30 member 8 (SLC30A8) zinc transporter for our study based on its role in insulin packaging. Zinc has been associated with insulin biosynthesis \[[@pone.0121855.ref006]\], and chronic decreased zinc intake has been associated with an increased risk of diabetes \[[@pone.0121855.ref007]\]. Specifically, the SCL30A8 Zn transporter is expressed in the pancreatic beta-cell secretory vesicles, and is primarily responsible for transporting Zn from the cytoplasm into the secretory vesicles for insulin maturation, storage, and secretion \[[@pone.0121855.ref008]\]. The SNP rs13266634 has been shown to be associated with T2DM in multiple populations \[[@pone.0121855.ref009]--[@pone.0121855.ref017]\]. The risk allele in rs13266634 is C, while the minor allele is T \[[@pone.0121855.ref010],[@pone.0121855.ref018]\]. As SCL30A8 requires Zn for its catalytic function, it is particularly susceptible to competition from other divalent cations. Therefore, characterizing the differential risk this polymorphism confers on individual populations may help refine the determination of any association between T2DM and exposure to divalent heavy metals in the environment. We used the Database of Single Nucleotide Polymorphisms (dbSNP) \[[@pone.0121855.ref019]\] and subsequent literature searching to identify the prevalence of this SNP in various human populations.

Calculation of Population Attributable Risk {#sec009}
-------------------------------------------

Individual studies reporting increased odds of T2DM in Asian or European carriers of the rs13266634 polymorphism were identified from a previously published 2011 meta-analysis \[[@pone.0121855.ref008]\]. For this analysis, homozygous carriers of the risk allele (i.e., CC) were considered to be at greatest risk of developing T2DM compared to dominant carriers (i.e., CT and TT). Using information provided \[[@pone.0121855.ref008]\], studies were identified for inclusion if they provided enough information to calculate the total frequency of the CC genotype in the study population (i.e., either the actual genotype numbers for cases and controls or the risk allele frequency). If a study did not explicitly report genotype numbers for cases and controls, that study was still included in the analysis if the risk allele frequency was reported in the control and case populations. Assuming Hardy-Weinburg equilibrium in these populations, the expected number of carriers of the CC genotype can be calculated as follows: $$\text{Expected~CC=p}^{\text{2}}\text{n}$$ where *p* is the reported risk allele frequency, and *n* is the case and control study populations. Study specific frequencies of the CC genotype were calculated by summing the number of case and control carriers of the CC genotype and dividing by the total study population. Weighted CC genotype frequencies for Asian or European populations were then calculated using individual study sizes for the weights. In order to characterize the genetic risk the rs13266634 polymorphism confers to homozygous carriers, the population attributable risk (PAR) for each ethnicity was calculated as follows \[[@pone.0121855.ref020],[@pone.0121855.ref021]\]: $$\text{PAR=100~} \times \frac{\left( {\text{E} \times \left( \text{OR-1} \right)} \right)}{\text{(1+}\left( {\text{E} \times \left( \text{OR-1} \right)} \right)}$$ where *E* is the frequency of the CC genotype (calculated as described above) and *OR* is the reported odds ratio for developing T2DM in the study populations. The PAR is the proportion of T2DM cases in the various populations expected to occur solely due to the presence of the CC risk genotype. Pooled odds ratios and 95% confidence limits were calculated from individual studies as described previously \[[@pone.0121855.ref008]\]. Assuming a dominant model (i.e., CC vs. \[CT + TT\]), a fixed-effect model was used to calculate a pooled OR across all included Asian and European study populations. The pooled OR was considered statistically significant with Z-test p value \< 0.05. To determine whether using a fixed-effect model was appropriate, the heterogeneity of the individual studies was assessed using the Χ^2^-based Q test. Evidence of statistical heterogeneity was assumed if the p-value for the Q test was \< 0.10, or the I^2^ value was \> 50%. If evidence of heterogeneity was evident, a random-effects model was then used. The CC frequency and PAR for a single Mexican Mestizo population was calculated using information published in the available literature \[[@pone.0121855.ref022]\]. All statistical analyses were conducted using the R statistical package (version 3.0.1, the R Foundation for Statistical Computing).

Generating Hotspot Maps for California {#sec010}
--------------------------------------

The following demographic data for California on the census tract level were extracted from the 2007--2011 American Communities Survey: Caucasian population, Asian population, and Mexican (of any race) population \[[@pone.0121855.ref023]\]. Total population was calculated as the sum of the Caucasian, Asian-American, and Mexican populations (i.e., the "total" population for this analysis excludes population figures for any other ethnicities). For the purposes of identifying potential hotspots of T2DM incidence due to the rs1326634 polymorphism, the PARs calculated for European, Asian, and Mexican populations \[[@pone.0121855.ref008],[@pone.0121855.ref022]\] were assumed to be representative of the Caucasian, Asian, and Mexican (of any race) populations reported in the census data. The census tract level demographic data were joined to a census tract shapefile for California using ArcGIS (version 10.1). A weighted average PAR for the total population in each census tract was then calculated using the subgroup populations as the weights. By extension, subgroup-specific PARs for each census tract can be calculated by multiplying the population of that subgroup by the subgroup-specific PAR and then dividing by the total population; these values represent the proportion of T2DM cases expected to occur in the total population solely due to the presence of the risk allele in that specific subgroup. Shaded maps were constructed displaying the PAR (categorized by quintile) in each Californian census tract due to Caucasian, Asian-American, or Mexican-American populations individually, or in aggregate. Finally, "hotspots" of genetic T2DM susceptibility were identified by determining which counties in California had \>25% of their population (Caucasian, Asian-American, or Mexican-American only) residing in census tracts in the highest quintile for Total PAR. All maps were created using ArcGIS software by ESRI. ArcGIS and ArcMap are the intellectual property of ESRI and are used herein under license (Copyright ESRI, all rights reserved).

Results {#sec011}
=======

Of the studies previously identified \[[@pone.0121855.ref008]\], 22 studies (28 individual study populations, herein referred to as "cohorts") were included in the current analysis \[[@pone.0121855.ref010],[@pone.0121855.ref011],[@pone.0121855.ref013],[@pone.0121855.ref016],[@pone.0121855.ref024]--[@pone.0121855.ref041]\]. After careful consideration, the following cohorts were excluded from the analysis: 3 cohorts investigated non-European or Asian populations (Ashkenazi Jews and Pima Indians) \[[@pone.0121855.ref024],[@pone.0121855.ref042],[@pone.0121855.ref043]\], 2 cohorts utilized a non-case-control study design \[[@pone.0121855.ref044],[@pone.0121855.ref045]\], and 4 cohorts provided inadequate information to calculate genotype frequencies (see [Methods](#sec007){ref-type="sec"}) \[[@pone.0121855.ref009],[@pone.0121855.ref012],[@pone.0121855.ref017],[@pone.0121855.ref046]\]. Cohorts of African populations \[[@pone.0121855.ref016],[@pone.0121855.ref024],[@pone.0121855.ref047]\] were excluded from this analysis as the pooled OR for those cohorts was not statistically significantly increased (1.20 \[0.90--1.40\]) \[[@pone.0121855.ref008]\].

Initial prevalence information was obtained from the dbSNP database, which contains the HapMap data. The rs13266634 SNP has an estimated risk allele frequency in the Mexican population of 81% (CC/CT). In the Caucasian and Asian populations, the risk allele has an estimated prevalence of 73.6% and 55.6%, respectively. For the studies used in the pooled cohort OR and PAR calculations, average risk allele frequencies in T2DM cases for Caucasians (70.4%) and Asians (61.7%) were similar to those reported in the dbSNP database; the risk allele frequency in the Mexican Mestizo population included in this analysis \[[@pone.0121855.ref022]\] also was similar the reported value in the database. When a weighted CC genotype frequency was calculated for these three ethnicities, Mexican Mestizos had the highest CC frequency (56.3%), followed by Caucasians (47.4%) and Asians (37.0%) ([Table 1](#pone.0121855.t001){ref-type="table"}).

10.1371/journal.pone.0121855.t001

###### CC genotype frequencies for T2DM cases and controls, with calculated population attributable risks.

![](pone.0121855.t001){#pone.0121855.t001g}

  Cohort                 Cases (N)   Cases---CC Genotype                          Cases RAF                                     Controls (N)   Controls---CC Genotype                       Controls RAF                                  Total N   Total CC   Frequency CC Genotype   Weighted Frequency CC   PAR[^a^](#t001fn001){ref-type="table-fn"}
  ---------------------- ----------- -------------------------------------------- --------------------------------------------- -------------- -------------------------------------------- --------------------------------------------- --------- ---------- ----------------------- ----------------------- -------------------------------------------
  **Asian Cohorts**                                                                                                                                                                                                                                                                                            
  Horikoshi              860         328                                          0.604[^b^](#t001fn002){ref-type="table-fn"}   859            293                                          0.57[^b^](#t001fn002){ref-type="table-fn"}    1719      621        0.361                   0.370                   0.065
  Steinsthosdottir       1426        464                                          0.566                                         970            259                                          0.523                                         2396      723        0.302                                           
  Furukawa               405         151                                          0.616[^b^](#t001fn002){ref-type="table-fn"}   340            121                                          0.593[^b^](#t001fn002){ref-type="table-fn"}   745       272        0.365                                           
  Horikawa               1830        690                                          0.6                                           1574           522                                          0.56                                          3404      1212       0.356                                           
  Lee                    908         324                                          0.61[^b^](#t001fn002){ref-type="table-fn"}    502            156                                          0.558[^b^](#t001fn002){ref-type="table-fn"}   1410      480        0.340                                           
  Omori                  1614        651                                          0.633                                         1045           381                                          0.6                                           2659      1032       0.388                                           
  Sanghera               532         290                                          0.728[^b^](#t001fn002){ref-type="table-fn"}   349            188                                          0.732[^b^](#t001fn002){ref-type="table-fn"}   881       478        0.543                                           
  Hu                     1849        695[^b^](#t001fn002){ref-type="table-fn"}    0.613                                         1785           558[^c^](#t001fn003){ref-type="table-fn"}    0.559                                         3634      1253       0.345                                           
  Tabara                 493         162                                          0.591[^b^](#t001fn002){ref-type="table-fn"}   400            133                                          0.568[^b^](#t001fn002){ref-type="table-fn"}   893       295        0.330                                           
  Chauhan                2466        1578[^b^](#t001fn002){ref-type="table-fn"}   0.8                                           2539           1505[^c^](#t001fn003){ref-type="table-fn"}   0.77                                          5005      3084       0.616                                           
  Han                    992         386                                          0.62                                          1005           327                                          0.57                                          1997      713        0.357                                           
  Huang                  443         134                                          0.541                                         229            64                                           0.483                                         672       198        0.295                                           
  Lin                    1529        532[^b^](#t001fn002){ref-type="table-fn"}    0.59                                          1439           420[^c^](#t001fn003){ref-type="table-fn"}    0.54                                          2968      952        0.321                                           
  Ng                     1481        485[^b^](#t001fn002){ref-type="table-fn"}    0.572                                         1530           433[^c^](#t001fn003){ref-type="table-fn"}    0.532                                         3011      918        0.305                                           
  Ng                     761         299[^b^](#t001fn002){ref-type="table-fn"}    0.627                                         632            216[^c^](#t001fn003){ref-type="table-fn"}    0.585                                         1393      515        0.370                                           
  Ng                     799         278[^b^](#t001fn002){ref-type="table-fn"}    0.59                                          1516           514[^c^](#t001fn003){ref-type="table-fn"}    0.582                                         2315      792        0.342                                           
  Wu                     424         144[^b^](#t001fn002){ref-type="table-fn"}    0.583                                         2786           899[^c^](#t001fn003){ref-type="table-fn"}    0.568                                         3210      1043       0.325                                           
  Xiang                  521         175[^b^](#t001fn002){ref-type="table-fn"}    0.579                                         721            203[^c^](#t001fn003){ref-type="table-fn"}    0.53                                          1242      377        0.304                                           
  Tan                    1541        433[^b^](#t001fn002){ref-type="table-fn"}    0.53                                          2196           617[^c^](#t001fn003){ref-type="table-fn"}    0.53                                          3737      1050       0.281                                           
  Tan                    1076        375[^b^](#t001fn002){ref-type="table-fn"}    0.59                                          2257           733[^c^](#t001fn003){ref-type="table-fn"}    0.57                                          3333      1108       0.332                                           
  Tan                    246         146[^b^](#t001fn002){ref-type="table-fn"}    0.77                                          364            199[^c^](#t001fn003){ref-type="table-fn"}    0.74                                          610       345        0.566                                           
  **European Cohorts**                                                                                                                                                                                                                                                                                         
  Scott                  2342        1011                                         0.649                                         2397           891                                          0.609                                         4739      1902       0.401                   0.474                   0.092
  Sladek                 2562        1440                                         0.746[^b^](#t001fn002){ref-type="table-fn"}   2878           1413                                         0.699[^b^](#t001fn002){ref-type="table-fn"}   5440      2853       0.524                                           
  Steinthorsdottir       3776        1871                                         0.7                                           12361          5575                                         0.666                                         16137     7446       0.461                                           
  Zeggini                1550        794                                          0.712[^b^](#t001fn002){ref-type="table-fn"}   2866           1393                                         0.694[^b^](#t001fn002){ref-type="table-fn"}   4416      2187       0.495                                           
  Cauchi                 2715        1453                                         0.729[^b^](#t001fn002){ref-type="table-fn"}   4255           2114                                         0.705[^b^](#t001fn002){ref-type="table-fn"}   6970      3597       0.512                                           
  Cauchi                 828         360                                          0.74[^b^](#t001fn002){ref-type="table-fn"}    952            367                                          0.699[^b^](#t001fn002){ref-type="table-fn"}   1780      727        0.408                                           
  Cauchi                 437         240                                          0.653[^b^](#t001fn002){ref-type="table-fn"}   676            331                                          0.626[^b^](#t001fn002){ref-type="table-fn"}   1113      571        0.513                                           
  **Mexican Cohorts**                                                                                                                                                                                                                                                                                          
  Gamboa-Meléndez        1027        609                                          0.77                                          990            526                                          0.729                                         2017      1135       0.563                   ---                     0.138

^a^ PAR calculated using ORs of 1.19, 1.21, and 1.28 for Asian, Caucasian, and Mexican cohorts, respectively;

^b^ risk allele frequency calculated from provided genotype incidences assuming Hardy-Weinberg equilibrium;

^c^ calculated assuming Hardy-Weinberg equilibrium: numbers with CC Genotype = p^2^n, where p is the risk allele frequency and n is the number of cases or controls

When calculating pooled ORs for the Asian and Caucasian cohorts included in subsequent PAR calculations, homozygous carriers of the CC genotype were observed to have a statistically significant increase in the odds of having T2DM compared to those with the CT or TT genotype: OR = 1.19, 95% CI: 1.06--1.33, p \< 0.01; OR = 1.21, 95% CI: 1.13--1.30, p \< 0.001, respectively. Results for the Asian cohorts were similar when all cohorts were used (above [results](#sec011){ref-type="sec"}) or when only the studies that reported explicit CC genotype numbers were used (OR = 1.20, 95% CI: 1.04--1.37, p \< 0.01); therefore, results using all cohorts were used in the PAR calculation for the Asian population. As all included Caucasian cohorts reported explicit CC genotype numbers, no sub-analysis was necessary. No evidence of heterogeneity was observed in either group of cohorts (Asians: I^2^ = 0, p = 0.46; Caucasians: I^2^ = 10.4, p = 0.35). Using a random-effects model to calculate the pooled ORs resulted in similar results for both Asian and Caucasian cohorts (results not shown). Using reported data \[[@pone.0121855.ref022]\], homozygous carriers of the CC genotype in Mexican Mestizos were also observed to have a statistically significant increase in the odds of having T2DM: OR = 1.28, 95% CI: 1.08--1.53.

The genetic prevalence data and pooled ORs were used to calculate PAR values for the individual ethnic groups ([Table 1](#pone.0121855.t001){ref-type="table"}). Mexican Mestizos had the highest PAR of the three ethnicities (0.138), more than double the risk in Asian-American populations (PAR = 0.065); Caucasians were observed to have a PAR of 0.092. PAR values for the three ethnicities were then combined with the census (tract level) data to generate PAR maps (categorized by quintiles). These PAR maps ([S1](#pone.0121855.s001){ref-type="supplementary-material"}--[S4](#pone.0121855.s004){ref-type="supplementary-material"} Figs) present the geographic distribution across California of the proportion of T2DM cases due solely to the rs13266634 SNP in the SLC30A8 gene for individual ethnicities and the total population in aggregate. For example, when investigating the expected prevalence of T2DM due to the Asian-American population in California, the PAR is very low (\> 1%) across the majority of the state ([S1 Fig](#pone.0121855.s001){ref-type="supplementary-material"}). This reflects that the small number of Asian-Americans living in rural portions of California contributes very little to the expected prevalent cases of T2DM in those areas. Conversely, the PAR due to solely to the Caucasian population in these areas is much higher (\~6--9% prevalent cases of T2DM, [S2 Fig](#pone.0121855.s002){ref-type="supplementary-material"}), reflecting the larger percentage of the total population Caucasians represent in these areas, and thus the larger contribution that population makes to T2DM prevalence. The greatest values for T2DM PAR are located in areas where Mexican-Americans (of any race) make up a large portion of the population: the San Joaquin Valley, near and within Los Angeles (Inland Empire), and southern California (e.g., San Diego and Imperial and Riverside counties) ([S3 Fig](#pone.0121855.s003){ref-type="supplementary-material"}). As should be expected, the PAR values for the total population are highest in areas with a larger Mexican population and lowest in the regions with the greatest Asian-American populations ([S4 Fig](#pone.0121855.s004){ref-type="supplementary-material"}). This pattern is more discernable when only the lowest (\<9.18) and highest (\>11.08) quintiles of total PAR are mapped ([Fig 1](#pone.0121855.g001){ref-type="fig"}). Total PAR values can be additionally be combined with information on T2DM prevalence to estimate the percentage of the total population (not just percentage of T2DM cases) that are at increased risk of developing T2DM due to the rs13266634 SNP ([Fig 2](#pone.0121855.g002){ref-type="fig"}). The Centers for Disease Control estimate the age-adjusted percentage of people over the age of 20 with diagnosed diabetes (2010--2012) as 4.4% for Chinese, 13.0% for Asian Indians, 8.8% for other Asians, 7.6% for non-hispanic whites, and 13.9% for Mexican-Americans, and 13.2% for African-Americans \[[@pone.0121855.ref048]\]. Using the specific prevalence rates for individual Asian ethnic groups, a weighted average of 7.2% for the Asian population as a whole (based on the individual Ns from the Asian cohorts in this analysis) was calculated. Combining this prevalence data with census tract population figures for all ethnicities, an average of 0.98% of the population across census tracts is at increased risk of developing T2DM due to the CC risk genotype. This corresponds to approximately 414,000 Californians at risk (95% CI: 179,000--640,000).

![Geographic distribution of low and high PAR Census tracts across California.\
Census tracts in the green and red are those in the lowest and highest quintiles for Total PAR, respectively.](pone.0121855.g001){#pone.0121855.g001}

![Percent of total population at increased risk of developing T2DM.\
Geographic distribution across the state of California for percent of population at increased risk of developing T2DM due to the rs13266634 single nucleotide polymorphism.](pone.0121855.g002){#pone.0121855.g002}

As decisions regarding remediation and/or intervention strategies may be more likely made on larger geographic units than census tracts, counties that contained census tracts in the highest total PAR quintile (Q5 census tract) were identified ([Table 2](#pone.0121855.t002){ref-type="table"}). In total, 1598 Q5 census tracts were identified, with approximately 24% of the total state population residing in those census tracts. A majority of California counties (32 counties) contained at least one Q5 census tract. Only two counties (Imperial and Monterey counties) had a majority of their population residing in Q5 census tracts (95% and 52%, respectively). However, half of the counties (16) had more than 25% of their population residing in Q5 census tracts, and 66% of counties (21) had more than 10% of the population in Q5 census tracts.

10.1371/journal.pone.0121855.t002

###### Counties with at least one Census Tract in the highest quintile of Total PAR.

![](pone.0121855.t002){#pone.0121855.t002g}

  County            \# Q5 Census Tracts[^a^](#t002fn001){ref-type="table-fn"}   Population of Q5 Census Tracts   Total County Population[^b^](#t002fn002){ref-type="table-fn"}   \% County Population in Q5 Census Tract
  ----------------- ----------------------------------------------------------- -------------------------------- --------------------------------------------------------------- -----------------------------------------
  Imperial          27                                                          243917                           256229                                                          95.19
  Monterey          34                                                          284769                           547350                                                          52.03
  Tulare            33                                                          309791                           625850                                                          49.50
  Kern              57                                                          461007                           1009155                                                         45.68
  Merced            18                                                          149471                           328035                                                          45.57
  Madera            7                                                           85188                            204339                                                          41.69
  San Benito        4                                                           30285                            74766                                                           40.51
  Kings             9                                                           78545                            194112                                                          40.46
  Colusa            2                                                           10752                            26680                                                           40.30
  San Bernardino    133                                                         900444                           2317432                                                         38.86
  Fresno            65                                                          429636                           1110640                                                         38.68
  Los Angeles       758                                                         3792716                          10431176                                                        36.36
  Ventura           43                                                          322307                           964413                                                          33.42
  Riverside         126                                                         796176                           2503008                                                         31.81
  Santa Cruz        10                                                          96146                            313820                                                          30.64
  Santa Barbara     16                                                          153888                           522385                                                          29.46
  Orange            78                                                          623963                           3367394                                                         18.53
  Stanislaus        15                                                          109064                           638912                                                          17.07
  Glenn             1                                                           5266                             33053                                                           15.93
  San Diego         83                                                          559336                           3565553                                                         15.69
  San Joaquin       18                                                          97050                            777986                                                          12.47
  Sutter            1                                                           8183                             106353                                                          7.69
  San Mateo         7                                                           49375                            760551                                                          6.49
  Alameda           24                                                          82034                            1431291                                                         5.73
  Santa Clara       19                                                          107898                           1954032                                                         5.52
  Contra Costa      7                                                           44313                            1047349                                                         4.23
  Sonoma            3                                                           20487                            530552                                                          3.86
  Yuba              1                                                           6515                             223305                                                          2.92
  Marin             1                                                           6825                             245102                                                          2.78
  Sacramento        4                                                           23590                            1387263                                                         1.70
  San Luis Obispo   1                                                           3873                             291604                                                          1.33
  Tuolumne          1                                                           496                              56009                                                           0.89

^a^ Census tracts in the highest quintile of total PAR as identified in [Fig 2](#pone.0121855.g002){ref-type="fig"}.

^b^ Total population in county calculated as the sum of all census tracts in that county

Discussion {#sec012}
==========

The current analysis presents a predictive risk screening approach to identifying census tract locations of communities potentially at risk of developing chronic diseases due to genetic susceptibility factors. Through the mining of genome-wide association study databases, we were able to identify genes encoding proteins that rely upon metals for their catalytic activity, and their relationship to T2DM. A similar approach has been used previously: an environment-wide association study (EWAS) using survey-weighted logistic regression was conducted on the NHANES data from 1999--2006 to identify chemical exposures and nutrients that may be associated with T2DM \[[@pone.0121855.ref049]\]. They found statistically significant odds ratios for PCB170, hepatachlor epoxide, and the nutrients cis-beta-carotene, trans-beta-carotene, and gamma-tocopherol across more than one NHANES cohort.

We used prevalence information about the SLC30A8 gene polymorphism rs13266634 to perform a geographic and demographic-based predictive screening pilot focused on the State of California. In this pilot we identified census tracts with elevated PAR for developing T2DM based on the prevalence of rs13266634 in various human populations. Census tracts with a higher PAR will likely contain individuals who may respond more poorly to chemical exposures.

While this study highlights a method for incorporating information on markers of genetic susceptibility with data on the spatial distribution of potentially susceptible populations, there are important limitations that warrant discussion. This analysis used multiple studies \[[@pone.0121855.ref010],[@pone.0121855.ref011],[@pone.0121855.ref013],[@pone.0121855.ref016],[@pone.0121855.ref024]--[@pone.0121855.ref041]\] to investigate associations between the rs1326664 C/T polymorphism in the SLC30A8 gene and prevalence of T2DM in Asian and European populations, but only one study to characterize risk in Mexican populations \[[@pone.0121855.ref022]\]. Confidence in the Mexican PAR value may therefore be lower than PAR values calculated for the Caucasian and Asian populations as those values were calculated using pooled ORs. Additionally, the pooled European and Asian ORs and the single Mexican OR have not adjusted for possible confounders. By not including confounders in the present meta-analysis, it is possible that the raw ORs may not adequately account for the contributions of other environmental or behavioral components of T2DM risk. However, the majority of studies from which the individual cohorts were drawn did account for numerous confounders (e.g., age, sex, obesity), and the ORs (both allele- and genotype-specific) calculated in those studies remained statistically significant after adjustment. Therefore, it is likely that any pooled OR estimated via meta-analytical techniques from these studies would also remain statistically significant. Regardless, if this methodology were to be used in an actual risk screening effort, more rigorous meta-analytical techniques that do incorporate information on confounders should be considered.

Although the current analysis independently calculated pooled ORs from the Asian and European cohorts, African cohorts were not included as the reported association between the C/T polymorphism and T2DM was not statistically significant in a pooled analysis (OR: 1.20, 95% CI: 0.90--1.40) \[[@pone.0121855.ref008]\]. As a result, when calculating the ethnicity-specific and total PAR for California census tracts, the African-American populations in individual census tracts were excluded. Although the primary goal of the current analysis is a "proof-of-concept" for integrating multiple sources of genetic, spatial, and health effects data to characterize population-level risks, omission of the African-American populations limits the interpretability of the PAR mapping results. In census tracts with large African-American populations, the true total PAR may be different from the current results depending on CC frequencies in African-Americans and which OR was used in the PAR calculations.

In future analyses, the African-American population could be incorporated in one of three ways. The first method would be to simply incorporate elevated ORs for African cohorts (i.e., \>1.0) ignoring statistical significance. A second approach would be to acknowledge that the increase in the pooled African OR is not statistically significant, and to include the African-American population numbers in the denominator when calculating the population-weighted total PAR ([Eq 2](#pone.0121855.e002){ref-type="disp-formula"}). This would be equivalent to calculating a PAR for African-Americans using an OR equal to 1 (thus, the PAR would be calculated to be zero). However, this approach would give undue weight to the risks in other ethnicities as it considers the central estimate of risk for those populations while ignoring the observed, albeit non-statistically significant, increase in the central estimate of risk in the African cohorts. The third alternative would be to calculate the PAR values based on the lower limit of the 95% confidence interval for each ethnicity, substituting 1.0 for the African cohorts. This approach would represent the most conservative estimate of risk of T2DM due to the CC genotype, but would incorporate the risk in each ethnicity equivalently.

Another limitation in the current analysis is how ethnicity-specific information has been incorporated. First, smaller ethnic groups have been aggregated into larger sets for the purpose of calculating the PAR. For example, study populations that have been described as Asian in this analysis are made up of Han Chinese, Korean, Japanese, and Asian Indian populations. Grouping different, distinct ethnic groups, each with their individual risks, allele frequencies, and spatial distributions, most likely masks true patterns in genetic susceptibility. Disaggregated information is available on these populations on the census tract level from the Census Bureau, and could be incorporated in future analyses. However, consideration of the smaller ethnic groupings may result in issues discussed above, namely findings of non-statistically significant risks for some smaller ethnic groups. Another assumption of this analysis is that the PAR calculated from the Asian, European, and Mexican Mestizos cohorts are representative of Asian, Caucasian, and Mexican-American populations in the United States. This may be true for populations of recent immigrants, but established ethnic populations could be sufficiently different such that the PARs calculated are not representative of the true risk for multiple reasons, especially differing risk allele frequencies. In order to minimize the uncertainty in whether this assumption is true, studies investigating the risk in these populations actually living in the United States would need to be identified and incorporated into the analysis. Lastly, race and Hispanic origin are considered separate concepts by the Census Bureau, and data regarding these self-reported identities are collected independently \[[@pone.0121855.ref050]\]. In the current analysis, the Mexican-American population category is listed as "Mexican---of any race", meaning that those self-identifying as Mexican can also self-identify as Caucasian, African-American, etc. This is a source of uncertainty as it is likely that some unknown proportion of the population in individual census tracts have been counted twice (as both Caucasian and Mexican) in PAR calculations.

A natural extension of the current study is to investigate whether spatial patterns of T2DM risk due to genetic susceptibility correlate with spatial patterns of environmental pollutants, other determinants of disease, and T2DM prevalence. Future studies could locate spatially-resolved data on contamination from sources such as EPA's Toxic Release Inventory (<http://www2.epa.gov/toxics-release-inventory-tri-program>) or National Priorities List (<http://www.epa.gov/superfund/sites/npl/>), and compare the clustering of high levels of contamination with the spatial patterns of total PAR distribution. Other sources of vulnerability to disease (poverty, socioeconomic status) could be incorporated into future analysis using currently available tools such as the CDC's Social Vulnerability Index ([www.svi.cdc.gov](http://www.svi.cdc.gov)). Publically available information on T2DM prevalence is most likely only available on the county level. This discrepancy in spatial resolution between T2DM data and contaminant and PAR data would be a challenge in determining if census tracts with increased genetic susceptibility and environmental contamination also are observed to have increased T2DM rates.

Conclusions {#sec013}
===========

This study describes a method for performing predictive risk screening to identify census tracts which may contain populations with increased genetic susceptibility to developing T2DM. In our pilot project, we have identified several census tracts within the State of California where potentially susceptible individuals live, suggesting these are potential areas where there may be environmental justice concerns. Concerns regarding environmental justice would be more pressing if the areas with elevated genetic susceptibility were collocated with areas with increased exposure to environmental pollutants also associated with T2DM risk.

This methodology potentially enables risk managers and policymakers to prioritize sites for cleanup and regulatory action, as well as help inform local decisions about commercial and industrial siting, zoning, and land use. In addition, this predictive screening approach may facilitate the problem formulation step of future risk assessments by identifying possible associations between disease endpoints and chemical exposures, and estimating the size of potentially susceptible populations across the United States. This will also facilitate environmental justice screening by allowing risk assessors and risk managers to identify communities which may bear a disproportionate risk due to their demographics and genetic susceptibility.
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###### Geographic distribution of PAR for Mexican-Americans across California.
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###### Geographic distribution of Total PAR across California.

Total PAR is the subgroup population-weighted average PAR for the total population in each census tract (i.e., the sum of the Asian-American, Caucasians, and Mexican-American populations, see [Methods](#sec007){ref-type="sec"}).
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